Ambrx Biopharma, Inc. 10975 Torrey Pines Road La Jolla, CA 92037Executive Employment Agreement • March 30th, 2023 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances)
This letter agreement (this “Amendment”) memorializes certain amendments to your executive employment agreement, dated June 4, 2021 (the “Employment Agreement”), between you and Ambrx Biopharma, Inc. (the “Company”), as set forth below.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 30th, 2023 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (“Agreement”) is made effective as of November 1, 2022 (“Effective Date”), by and between Ambrx, Inc., a Delaware corporation (the “Company”), and Daniel J. O’Connor (the “Executive”) (collectively, the “Parties”, and individually, a “Party”).
ContractRetention Agreement • March 30th, 2023 • Ambrx Biopharma Inc. • Biological products, (no disgnostic substances)
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
